A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19
코로나19에 대한 렘데시비르, 하이드록시클로로퀸, 로피나비르-리토나비르 치료의 전임상 및 임상 효능 검토
Review
Published on
Journal: SLAS discovery : advancing life sciences R & D [Category] SARS, 비임상, 신약개발, 임상, 치료법, 치료제,
Journal: SLAS discovery : advancing life sciences R & D [Category] SARS, 비임상, 신약개발, 임상, 치료법, 치료제,
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
age
animal model
Anosmia
approved
Atypical
Atypical pneumonia
beta-coronavirus
breath
candidate
capital city
cardiovascular disease
characterized
China
clinical
Clinical studies
clinical study
clinically
combinations
Compound
coronavirus
Coronavirus 2019
cough
COVID-19
COVID-19 patient
diabetes
Diabetes Mellitus
disease
drug
Efficacy
Emergency use
Epidemiological investigation
Epidemiological investigations
Fever
gastrointestinal symptoms
health emergency
Health Organization
Hydroxychloroquine
in vitro
include
Infectious virus
Lopinavir
Lopinavir-ritonavir
malaise
novel
Novel coronavirus
outbreak
outcome
pandemic
pathogen
Pneumonia
Preclinical
protocol
Remdesivir
respiratory
review
Ritonavir
RNA
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severe cases
Shortness of breath
Spread
suggested
Symptom
these compounds
treat
treatment for COVID-19
Typical
typical symptoms
virus
WHO
World Health Organization
Wuhan
[DOI] 10.1177/2472555220958385 PMC 바로가기 [Article Type] Review
[DOI] 10.1177/2472555220958385 PMC 바로가기 [Article Type] Review